Design And Development Of New Therapeutics Against Infectious Diseases Using Computational And Experimental Approaches

Design and development of new therapeutics against infectious diseases using computational and experimental approaches

Infectious diseases are caused by bacteria, fungus, viruses, and other microorganisms. Biomolecules such as proteins, DNA, and/or RNA play a crucial role in the infections of these disorders. These infectious illnesses are often transmissible, meaning they may be passed from one person to another by a variety of means. Even though medical technology has progressed, some illnesses continue to cause anxiety among individuals worldwide. If we examine the situation of COVID-19, the entire world is terrified of the pandemic. Similarly, In the last decades, other infections including Dengue, Chikungunya, Zika, Ebola, Japanese Encephalitis Virus (JEV), influenza, the common cold, tuberculosis (TB), Hepatitis A and B and human immunodeficiency syndrome (HIV) have also challenged the human population.

Multidisciplinary Research in Arts, Science & Commerce (Volume-19)

Structure-Based Drug Design

This volume focuses on target-oriented approximations to drug discovery, including target selection, binding pocket detection, and current uses and variants of molecular dynamics and molecular docking. The primary audience is PhD and graduates working in the field of molecular biology, structural biology, pharmaceutical sciences.